Clearmind Medicine (CMND) Competitors $1.44 -0.05 (-3.36%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends CMND vs. BCDA, KPRX, PHIO, TLPH, INDP, CDT, ENSC, MYNZ, SPRC, and BFRIShould you be buying Clearmind Medicine stock or one of its competitors? The main competitors of Clearmind Medicine include BioCardia (BCDA), Kiora Pharmaceuticals (KPRX), Phio Pharmaceuticals (PHIO), Talphera (TLPH), Indaptus Therapeutics (INDP), Conduit Pharmaceuticals (CDT), Ensysce Biosciences (ENSC), Mainz Biomed (MYNZ), SciSparc (SPRC), and Biofrontera (BFRI). These companies are all part of the "pharmaceutical products" industry. Clearmind Medicine vs. BioCardia Kiora Pharmaceuticals Phio Pharmaceuticals Talphera Indaptus Therapeutics Conduit Pharmaceuticals Ensysce Biosciences Mainz Biomed SciSparc Biofrontera BioCardia (NASDAQ:BCDA) and Clearmind Medicine (NASDAQ:CMND) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, dividends and community ranking. Do analysts prefer BCDA or CMND? BioCardia currently has a consensus price target of $25.00, indicating a potential upside of 1,052.07%. Given BioCardia's stronger consensus rating and higher probable upside, research analysts plainly believe BioCardia is more favorable than Clearmind Medicine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioCardia 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Clearmind Medicine 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in BCDA or CMND? BioCardia received 16 more outperform votes than Clearmind Medicine when rated by MarketBeat users. CompanyUnderperformOutperformBioCardiaOutperform Votes1659.26% Underperform Votes1140.74% Clearmind MedicineN/AN/A Is BCDA or CMND more profitable? Clearmind Medicine has a net margin of 0.00% compared to BioCardia's net margin of -1,999.77%. BioCardia's return on equity of 0.00% beat Clearmind Medicine's return on equity.Company Net Margins Return on Equity Return on Assets BioCardia-1,999.77% N/A -208.38% Clearmind Medicine N/A -238.73%-102.10% Do institutionals and insiders hold more shares of BCDA or CMND? 20.6% of BioCardia shares are held by institutional investors. Comparatively, 96.1% of Clearmind Medicine shares are held by institutional investors. 20.0% of BioCardia shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media refer more to BCDA or CMND? In the previous week, BioCardia's average media sentiment score of 1.00 beat Clearmind Medicine's score of 0.00 indicating that BioCardia is being referred to more favorably in the media. Company Overall Sentiment BioCardia Positive Clearmind Medicine Neutral Which has more risk and volatility, BCDA or CMND? BioCardia has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Comparatively, Clearmind Medicine has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Which has preferable earnings and valuation, BCDA or CMND? Clearmind Medicine has lower revenue, but higher earnings than BioCardia. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioCardia$480K20.71-$11.57M-$4.19-0.52Clearmind MedicineN/AN/A-$8.62MN/AN/A SummaryBioCardia beats Clearmind Medicine on 9 of the 13 factors compared between the two stocks. Get Clearmind Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for CMND and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CMND vs. The Competition Export to ExcelMetricClearmind MedicinePharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.44M$6.55B$5.38B$9.11BDividend YieldN/A2.96%5.37%4.00%P/E RatioN/A9.7087.8117.51Price / SalesN/A334.591,285.9980.25Price / CashN/A22.6336.6032.90Price / Book0.345.064.944.66Net Income-$8.62M$154.90M$117.96M$224.69M7 Day Performance-4.30%2.31%2.29%3.11%1 Month Performance20.42%1.25%3.26%5.17%1 Year Performance39.75%4.88%27.03%22.24% Clearmind Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CMNDClearmind Medicine0.4201 of 5 stars$1.44-3.4%N/A+44.1%$2.43MN/A0.00N/ABCDABioCardia3.56 of 5 stars$2.25+5.6%$25.00+1,011.1%-66.7%$10.31M$71,000.00-0.5440Positive NewsGap DownKPRXKiora Pharmaceuticals3.2661 of 5 stars$3.41-3.1%$10.00+193.3%-20.6%$10.23M$16M0.0010Gap UpPHIOPhio Pharmaceuticals2.5106 of 5 stars$6.60+290.5%$36.00+445.5%-54.4%$9.85MN/A-0.6010Gap UpHigh Trading VolumeTLPHTalphera3.4266 of 5 stars$0.58-4.0%$4.50+681.0%-23.9%$9.81M$281,000.00-0.8419Analyst ForecastNews CoverageGap DownINDPIndaptus Therapeutics3.2567 of 5 stars$0.950.0%$8.50+794.9%-51.4%$9.69MN/A-0.566CDTConduit PharmaceuticalsN/A$0.09-24.4%N/A-97.5%$9.59MN/A0.003Positive NewsGap DownENSCEnsysce Biosciences0.0141 of 5 stars$7.17-4.3%N/A-54.6%$9.36M$2.23M-0.2610MYNZMainz Biomed2.6555 of 5 stars$4.67+9.1%$120.00+2,469.6%-88.8%$9.35M$917,203.00-0.0730News CoveragePositive NewsGap UpSPRCSciSparc0.4931 of 5 stars$0.85+4.9%N/A-82.0%$8.85M$1.75M0.004Gap DownBFRIBiofrontera2.5991 of 5 stars$1.13+0.9%$7.00+519.5%-32.9%$8.76M$35.36M-0.5070News CoveragePositive News Related Companies and Tools Related Companies BCDA Competitors KPRX Competitors PHIO Competitors TLPH Competitors INDP Competitors CDT Competitors ENSC Competitors MYNZ Competitors SPRC Competitors BFRI Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CMND) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearmind Medicine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearmind Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CMND Stock Alerts